Skriver L, Larsson L I, Kielberg V, Nielsen L S, Andresen P B, Kristensen P, Danø K
J Cell Biol. 1984 Aug;99(2):753-7. doi: 10.1083/jcb.99.2.753.
The invasively growing and metastasizing Lewis lung carcinoma consistently contained urokinase-type plasminogen activator (u-PA) enzyme activity. When investigated immunocytochemically with antibodies against u-PA, different parts of individual tumors showed a pronounced heterogeneity in staining intensity. Strong staining was found in areas with invasive growth and degradation of surrounding normal tissue, while other areas were completely devoid of staining. Immunoreactivity occurred both with a perinuclear cytoplasmic localization in tumor cells and associated with apparently extracellular material. SDS PAGE of tumor extracts, under both reducing and nonreducing conditions, followed by immunoblotting, showed only one immunocytochemically stainable band with an electrophoretic mobility corresponding to that of purified proenzyme to u-PA, while no two-chain u-PA was detected. This indicates that the major part of the activator in Lewis lung carcinoma is present as one-chain pro-u-PA.
具有侵袭性生长和转移特性的Lewis肺癌始终含有尿激酶型纤溶酶原激活剂(u-PA)酶活性。当用抗u-PA抗体进行免疫细胞化学研究时,单个肿瘤的不同部位在染色强度上表现出明显的异质性。在侵袭性生长并降解周围正常组织的区域发现强染色,而其他区域则完全没有染色。免疫反应性既出现在肿瘤细胞的核周细胞质定位中,也与明显的细胞外物质相关。在还原和非还原条件下对肿瘤提取物进行SDS-PAGE,随后进行免疫印迹分析,结果显示只有一条免疫细胞化学可染色带,其电泳迁移率与纯化的u-PA酶原相对应,而未检测到双链u-PA。这表明Lewis肺癌中激活剂的主要部分以单链pro-u-PA的形式存在。